Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA3 | P07451 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | CA6 | P23280 | 1/20 | 0.45 |
| ▸ | CA5A | P35218 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.45 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL29881172 | 0.90 | LMNA (0.50) | LMNACA12CA1CA2CA3 | |
| SCHEMBL39044 | 0.86 | — | — | |
| SCHEMBL27689543 | 0.86 | — | — | |
| SCHEMBL1817230 | 0.84 | ALDH1A1 (0.44) | LMNACA12CA1CA2CA3 | |
| Acrylic Acid SCHEMBL21798556 | 0.83 | LMNA (0.45) | LMNACA12CA1CA2CA3 | |
| Urea SCHEMBL14776158 | 0.82 | LMNA (0.59) | LMNACA12CA1CA2CA3 | |
| SCHEMBL7198087 | 0.80 | LMNA (0.46) | LMNACA12CA1CA2CA3 | |
| SCHEMBL8558383 | 0.78 | LMNA (0.44) | LMNACA12CA1CA2CA3 | |
| Methylpyrrolidone SCHEMBL5063791 | 0.77 | BRD4 (0.63) | LMNACA12CA1CA2CA3 | |
| SCHEMBL4154528 | 0.75 | LMNA (0.44) | LMNACA12CA1CA2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912831-B2 | Hydroxyethylpyrrolidone ethacrylate/glycidyl ethacrylate copolymers | ISP INVESTMENTS LLC (US) | 2024-02-27 | — | — | US | claimed |
| EP-3884963-A1 | NAPROXEN/DEXAMETHASONE-BASED NANOPARTICLES | Consejo Superior de Investigaciones Científicas (CSIC) (ES) | 2021-09-29 | — | — | EP | claimed |
| EP-3377546-B1 | PROCESS FOR THE PREPARATION OF HYDROXYETHYLPYRROLIDONE METHACRYLATE/GLYCIDYL METHACRYLATE COPOLYMERS | ISP INVESTMENTS LLC (US) | 2020-10-21 | — | — | EP | claimed |
| US-10274852-B2 | Coating compositions for forming toner coatings | ISP INVESTMENTS LLC (US) | 2019-04-30 | — | — | US | claimed |
| US-20180346627-A1 | HYDROXYETHYLPYRROLIDONE METHACRYLATE/GLYCIDYL METHACRYLATE COPOLYMERS | ISP INVESTMENTS LLC (US) | 2018-12-06 | — | — | US | claimed |
| US-20180346628-A1 | POLYMERS FOR ORAL CARE COMPOSITIONS | ISP INVESTMENTS LLC (US) | 2018-12-06 | — | — | US | claimed |
| US-20180327628-A1 | COATING COMPOSITIONS FOR FORMING TONER COATINGS | ISP INVESTMENTS LLC (US) | 2018-11-15 | — | — | US | claimed |
| WO-2018106666-A1 | ORAL CARE COPOLYMERS AND COMPOSITIONS AND METHODS FOR USE | ISP INVESTMENTS LLC (US) | 2018-06-14 | — | — | WO | claimed |
| US-9821589-B2 | Coating compositions for forming toner receptive coatings | ISP INVESTMENTS LLC (US) | 2017-11-21 | — | — | US | claimed |
| US-20160282737-A1 | COATING COMPOSITIONS FOR FORMING TONER COATINGS | ISP INVESTMENTS INC. (US) | 2016-09-29 | — | — | US | claimed |
| US-20160059607-A1 | COATING COMPOSITIONS FOR FORMING TONER RECEPTIVE COATINGS | ISP INVESTMENTS INC. (US) | 2016-03-03 | — | — | US | claimed |
| US-20160053131-A1 | COATING COMPOSITIONS FOR FORMING TONER COATINGS | ISP INVESTMENTS INC. (US) | 2016-02-25 | — | — | US | claimed |
| WO-2014160604-A1 | COATING COMPOSITIONS FOR FORMING TONER COATINGS | ISP INVESTMENTS INC. (US) | 2014-10-02 | — | — | WO | claimed |
| WO-2014160631-A1 | COATING COMPOSITIONS FOR FORMING TONER COATINGS | ISP INVESTMENTS INC. (US) | 2014-10-02 | — | — | WO | claimed |
| WO-2014160672-A1 | COATING COMPOSITIONS FOR FORMING TONER RECEPTIVE COATINGS | ISP INVESTMENTS INC. (US) | 2014-10-02 | — | — | WO | claimed |
| EP-3377549-B1 | PROLIFEROUS POLYMERS COMPRISING LACTAMIC MOIETIES | ISP INVESTMENTS LLC (US) | 2024-09-04 | — | — | EP | disclosed |
| US-11912831-B2 | Hydroxyethylpyrrolidone ethacrylate/glycidyl ethacrylate copolymers | ISP INVESTMENTS LLC (US) | 2024-02-27 | — | — | US | disclosed |
| WO-2011063208-A1 | ALKYL LACTAM ESTER POLYMERS, AND USES THEREOF | ISP INVESTMENTS INC. (US) | 2011-05-26 | — | — | WO | disclosed |
| US-7750100-B2 | Catalytic process for preparing (meth)acrylates from N-hydroxyalkylated lactams | BASF AKTIENGESELLSCHAFT (DE) | 2010-07-06 | — | — | US | disclosed |
| US-20070123673-A1 | CATALYTIC PROCESS FOR PREPARING (METH)ACRYLATES FROM N-HYDROXYALKYLATED LACTAMS | BASF AKTIENGESELLSCHAFT (DE) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180346628-A1 | POLYMERS FOR ORAL CARE COMPOSITIONS | MPO, SMARCC1, PTMA | LMNA 1614/4885CA12 3205/4885CA1 1877/4885 |
| US-11912831-B2 | Hydroxyethylpyrrolidone ethacrylate/glycidyl ethacrylate copolymers | MMAB, PCNA, HMBS | LMNA 2499/4885CA12 1204/4885CA1 867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.